Hantech Bio-Technology Co., Ltd. (TPEX:1294)
Taiwan · Delayed Price · Currency is TWD 55.70
-1.10 (-1.94%)
Aug 20, 2026, 1:30 PM CST
Hantech Bio-Technology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 864.73 | 778.54 | 748.42 | 625.14 | 302.52 | 240.29 |
Revenue Growth | 20.00% | 4.02% | 19.72% | 106.65% | 25.90% | -9.90% |
Gross Profit Gross Profit Growth | 310.04 | 288.9 | 305.74 | 280.85 | 126.63 | 101.03 |
Operating Income Operating Income Growth | 183.76 | 172.98 | 197.47 | 185.71 | 56.84 | 39.67 |
Net Income Net Income Growth | 149.13 | 139.05 | 155.67 | 148.12 | 47.47 | 32.56 |
Earnings Per Share EPS Growth | 4.06 | 3.78 | 4.44 | 4.36 | 1.51 | 1.12 |
EPS Growth | 1.90% | -14.82% | 1.86% | 188.00% | 34.69% | -43.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 822.17 | 770.01 | 735.07 | 620.03 | 293.31 | 231.24 |
Other Other Growth | 3.11 | 1.9 | 2.48 | 1.51 | 9.21 | 9.06 |
China China Growth | - | 5.09 | 10.25 | 2.55 | - | - |
Singapore Singapore Growth | - | 1.54 | 0.63 | 1.06 | - | - |
Total Total Growth | 831.92 | 778.54 | 748.42 | 625.14 | 302.52 | 240.29 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 374.05 | 339.38 | 382.42 | 167.09 | 75.04 | 86.41 |
Total Debt Total Debt Growth | 107.4 | 113.28 | 158.83 | 330.27 | 118.83 | 144.75 |
Net Cash (Debt) Net Cash Growth | 266.65 | 226.1 | 223.6 | -163.18 | -43.79 | -58.33 |
Net Cash Growth | -11.25% | 1.12% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 7.26 | 6.15 | 6.38 | -4.80 | -1.40 | -2.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 152.3 | 160.63 | 150.75 | 191.91 | 63.18 | 44.39 |
Capital Expenditures CapEx Growth | -31.41 | -15.45 | -24.63 | -293.94 | -82.88 | -79.26 |
Free Cash Flow Free Cash Flow Growth | 120.89 | 145.19 | 126.13 | -102.03 | -19.7 | -34.87 |
Free Cash Flow Growth | -32.35% | 15.11% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 35.85% | 37.11% | 40.85% | 44.93% | 41.86% | 42.04% |
Operating Margin | 21.25% | 22.22% | 26.38% | 29.71% | 18.79% | 16.51% |
Pretax Margin | 21.47% | 22.22% | 26.01% | 29.52% | 19.08% | 15.99% |
Profit Margin | 17.25% | 17.86% | 20.80% | 23.69% | 15.69% | 13.55% |
FCF Margin | 13.98% | 18.65% | 16.85% | -16.32% | -6.51% | -14.51% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.500 | 2.500 | 2.667 | 0.582 | 0.506 |
Dividend Per Share Growth | 26.61% | -6.25% | 357.96% | 15.01% | - |
Dividend Yield | 4.46% | 3.96% | 4.10% | 1.04% | 2.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.71 | 17.13 | 16.52 | 13.66 | 17.19 | - |
Forward PE | - | 10.46 | 12.84 | - | - | - |
P/FCF Ratio | 16.74 | 16.41 | 20.40 | - | - | - |
PS Ratio | 2.34 | 3.06 | 3.44 | 3.24 | 2.70 | - |